202 related articles for article (PubMed ID: 31747477)
21. The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities.
Mazzetti M; Marconi G; Mancinelli M; Benedetti A; Marzioni M; Maroni L
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919600
[TBL] [Abstract][Full Text] [Related]
22. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Rust C; Beuers U
Clin Rev Allergy Immunol; 2005 Apr; 28(2):135-45. PubMed ID: 15879619
[TBL] [Abstract][Full Text] [Related]
23. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
Franco J; Saeian K
Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
[TBL] [Abstract][Full Text] [Related]
24. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
Bressler B; Pinto R; El-Ashry D; Heathcote EJ
Gut; 2005 Mar; 54(3):407-10. PubMed ID: 15710991
[TBL] [Abstract][Full Text] [Related]
25. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.
Bloom S; Fleming K; Chapman R
Gut; 1995 Apr; 36(4):604-9. PubMed ID: 7537707
[TBL] [Abstract][Full Text] [Related]
26. CTLA-4 Expression Plays a Role in PSC and PBC Progression.
Meister P; Steinke-Ramming C; Beste M; Lenzen H; Gerken G; Canbay A; Jochum C
Diseases; 2020 Jun; 8(2):. PubMed ID: 32545568
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy outcomes in women with primary biliary cholangitis and primary sclerosing cholangitis: a retrospective cohort study.
Cauldwell M; Mackie FL; Steer PJ; Henehghan MA; Baalman JH; Brennand J; Johnston T; Dockree S; Hedley C; Jarvis S; Khan S; McAuliffe FM; Mackillop L; Penna L; Smith B; Trivedi P; Verma S; Westbrook R; Winifield S; Williamson C
BJOG; 2020 Jun; 127(7):876-884. PubMed ID: 32012415
[TBL] [Abstract][Full Text] [Related]
28. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
[TBL] [Abstract][Full Text] [Related]
29. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway.
Kempinska-Podhorodecka A; Milkiewicz M; Wasik U; Ligocka J; Zawadzki M; Krawczyk M; Milkiewicz P
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146070
[TBL] [Abstract][Full Text] [Related]
30. A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome.
Terziroli Beretta-Piccoli B; Mazzucchelli L; Taiana C; Mossi G; Usai C; Vergani D; Mieli-Vergani G
J Transl Autoimmun; 2020; 3():100033. PubMed ID: 32743518
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
[TBL] [Abstract][Full Text] [Related]
32. ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis.
Kempinska-Podhorodecka A; Milkiewicz M; Jabłonski D; Milkiewicz P; Wunsch E
PLoS One; 2017; 12(4):e0176264. PubMed ID: 28426778
[TBL] [Abstract][Full Text] [Related]
33. CD14 is associated with biliary stricture formation.
Friedrich K; Smit M; Brune M; Giese T; Rupp C; Wannhoff A; Kloeters P; Leopold Y; Denk GU; Weiss KH; Stremmel W; Sauer P; Hohenester S; Schirmacher P; Schemmer P; Gotthardt DN
Hepatology; 2016 Sep; 64(3):843-52. PubMed ID: 26970220
[TBL] [Abstract][Full Text] [Related]
34. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis.
ter Borg PC; Fekkes D; Vrolijk JM; van Buuren HR
BMC Gastroenterol; 2005 Mar; 5():11. PubMed ID: 15790420
[TBL] [Abstract][Full Text] [Related]
35. Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.
Carpino G; Cardinale V; Folseraas T; Overi D; Floreani A; Franchitto A; Onori P; Cazzagon N; Berloco PB; Karlsen TH; Alvaro D; Gaudio E
Am J Pathol; 2018 Mar; 188(3):627-639. PubMed ID: 29248458
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Tinmouth J; Lee M; Wanless IR; Tsui FW; Inman R; Heathcote EJ
Liver; 2002 Jun; 22(3):228-34. PubMed ID: 12100573
[TBL] [Abstract][Full Text] [Related]
37. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
[TBL] [Abstract][Full Text] [Related]
38. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
39. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.
Sherlock S
Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193
[TBL] [Abstract][Full Text] [Related]
40. Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms.
Sebode M; Peiseler M; Franke B; Schwinge D; Schoknecht T; Wortmann F; Quaas A; Petersen BS; Ellinghaus E; Baron U; Olek S; Wiegard C; Weiler-Normann C; Lohse AW; Herkel J; Schramm C
J Hepatol; 2014 May; 60(5):1010-6. PubMed ID: 24412607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
